Recon: FDA mulls second COVID booster; GSK pauses some RSV vax trials
ReconDenise Fulton
Biologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsGlobalMedical DevicesOTCPharmaceuticalsReconDenise FultonBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsGlobalMedical DevicesOTCPharmaceuticals